Literature DB >> 22038965

Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.

Nicholas C K Heng1, Nurul S Haji-Ishak, Alaina Kalyan, Andrew Y C Wong, Marija Lovric, Joanna M Bridson, Julia Artamonova, Jo-Ann L Stanton, Philip A Wescombe, Jeremy P Burton, Mary P Cullinan, John R Tagg.   

Abstract

Streptococcus salivarius is a Gram-positive bacterial commensal and pioneer colonizer of the human oral cavity. Many strains produce ribosomally synthesized proteinaceous antibiotics (bacteriocins), and some strains have been developed for use as oral probiotics. Here, we present the draft genome sequence of the bacteriocin-producing oral probiotic S. salivarius strain M18.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22038965      PMCID： PMC3209194          DOI： 10.1128/JB.06001-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  11 in total

1.  Oral bacterial genome sequencing using the high-throughput Roche Genome Sequencer FLX System.

Authors:  Nicholas C K Heng; Jo-Ann L Stanton
Journal:  Methods Mol Biol       Date:  2010

2.  Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.

Authors:  Philip A Wescombe; Jeremy P Burton; Peter A Cadieux; Nikolai A Klesse; Otto Hyink; Nicholas C K Heng; Chris N Chilcott; Gregor Reid; John R Tagg
Journal:  Antonie Van Leeuwenhoek       Date:  2006-07-27       Impact factor: 2.271

3.  Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study.

Authors:  J P Burton; S Cowley; R R Simon; J McKinney; P A Wescombe; J R Tagg
Journal:  Food Chem Toxicol       Date:  2011-06-21       Impact factor: 6.023

4.  Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.

Authors:  P A Wescombe; M Upton; P Renault; R E Wirawan; D Power; J P Burton; C N Chilcott; J R Tagg
Journal:  Microbiology       Date:  2011-02-10       Impact factor: 2.777

5.  Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1.

Authors:  Yukihiro Takahashi; Kiyoshi Konishi; John O Cisar; Masanosuke Yoshikawa
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 6.  Bacterial replacement therapy: adapting 'germ warfare' to infection prevention.

Authors:  John R Tagg; Karen P Dierksen
Journal:  Trends Biotechnol       Date:  2003-05       Impact factor: 19.536

7.  Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.

Authors:  Philip A Wescombe; Mathew Upton; Karen P Dierksen; Nancy L Ragland; Senthuran Sivabalan; Ruth E Wirawan; Megan A Inglis; Chris J Moore; Glenn V Walker; Chris N Chilcott; Howard F Jenkinson; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

Review 8.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 9.  Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.

Authors:  Philip A Wescombe; Nicholas C K Heng; Jeremy P Burton; Chris N Chilcott; John R Tagg
Journal:  Future Microbiol       Date:  2009-09       Impact factor: 3.165

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969
View more
  15 in total

Review 1.  Probiotics or pro-healers: the role of beneficial bacteria in tissue repair.

Authors:  Jovanka Lukic; Vivien Chen; Ivana Strahinic; Jelena Begovic; Hadar Lev-Tov; Stephen C Davis; Marjana Tomic-Canic; Irena Pastar
Journal:  Wound Repair Regen       Date:  2018-02-09       Impact factor: 3.617

2.  Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

Authors:  Jeffrey A Banas; Eric T Popp
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

3.  Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization.

Authors:  Kathryn A Patras; Philip A Wescombe; Berenice Rösler; John D Hale; John R Tagg; Kelly S Doran
Journal:  Infect Immun       Date:  2015-06-15       Impact factor: 3.441

4.  Complete genome sequence of Streptococcus salivarius PS4, a strain isolated from human milk.

Authors:  Virginia Martín; Antonio Maldonado-Barragán; Esther Jiménez; Patricia Ruas-Madiedo; Leónides Fernández; Juan M Rodríguez
Journal:  J Bacteriol       Date:  2012-08       Impact factor: 3.490

5.  Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.

Authors:  Caroline Barretto; Pablo Alvarez-Martin; Francis Foata; Pierre Renault; Bernard Berger
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

6.  Acquisition through horizontal gene transfer of plasmid pSMA198 by Streptococcus macedonicus ACA-DC 198 points towards the dairy origin of the species.

Authors:  Konstantinos Papadimitriou; Rania Anastasiou; Eleni Maistrou; Thomas Plakas; Nikos C Papandreou; Stavros J Hamodrakas; Stéphanie Ferreira; Philip Supply; Pierre Renault; Bruno Pot; Effie Tsakalidou
Journal:  PLoS One       Date:  2015-01-13       Impact factor: 3.240

7.  Probiotic therapy as a novel approach for allergic disease.

Authors:  Zheng Quan Toh; Anzela Anzela; Mimi L K Tang; Paul V Licciardi
Journal:  Front Pharmacol       Date:  2012-09-21       Impact factor: 5.810

8.  Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.

Authors:  Jeremy P Burton; Philip A Wescombe; Jean M Macklaim; Melissa H C Chai; Kyle Macdonald; John D F Hale; John Tagg; Gregor Reid; Gregory B Gloor; Peter A Cadieux
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

9.  Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study.

Authors:  Francesco Di Pierro; Alberto Zanvit; Piero Nobili; Paolo Risso; Carlo Fornaini
Journal:  Clin Cosmet Investig Dent       Date:  2015-10-03

10.  Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.

Authors:  Abdelahhad Barbour; Koshy Philip
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.